Multiple Myeloma Molecular Monitoring Study (NCT03421132)
🩺 Plain-English Summary (8th-Grade Level)
The investigators will track 250 multiple myeloma patients across Canada over time, using new lab tests to evaluate their blood and bone marrow, as they receive standard of care treatment. The main hypothesis is that these tests will allow clinicians to better diagnose and manage multiple myeloma, improving patients' quality of life overall.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (3 items).
Location: Tom Baker Cancer Centre — Calgary, Alberta
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Ineligible for ASCT
- Does not consent to participate in MCRN database project
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (9 Sites)
- Tom Baker Cancer Centre — Calgary, Alberta
- Cross Cancer Institute — Edmonton, Alberta
- Vancouver General Hospital — Vancouver, British Columbia
- CancerCare Manitoba — Winnipeg, Manitoba
- Saint John Regional Hospital (Horizon Health Network) — Saint John, New Brunswick
- Queen Elizabeth II Health Sciences Centre — Halifax, Nova Scotia
- Buland Mangukia — Hamilton, Ontario
- Princess Margaret Cancer Centre — Toronto, Ontario
- McGill University Health Centre — Montreal, Quebec
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.